Global and United States Ventriculoperitoneal (VP) Shunt Market Report & Forecast 2022-2028

An implanted shunt diverts CSF from the ventricles within the brain or the subarachnoid spaces around the brain and spinal cord to another body region where it will be absorbed. This creates an alternative route for removal of CSF which is constantly produced within the brain and usually restores the physiological balance between CSF production, flow, and absorption when one or more of these functions has been impaired. Valves contained within the shunt pathway act like on-off switches, opening when the differential pressure (DP) – i.e., the pressure difference across the valve – exceeds the valve’s opening pressure. Valves are either set to a fixed pressure or they can be adjustable from outside the body. Accessory devices may be added to the shunt to modify valve function.
Market Analysis and Insights: Global and United States Ventriculoperitoneal (VP) Shunt Market
This report focuses on global and United States Ventriculoperitoneal (VP) Shunt market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Ventriculoperitoneal (VP) Shunt market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, Fixed Pressure Valves accounting for % of the Ventriculoperitoneal (VP) Shunt global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Hospitals was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Ventriculoperitoneal (VP) Shunt market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
Global Ventriculoperitoneal (VP) Shunt Scope and Market Size
Ventriculoperitoneal (VP) Shunt market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Ventriculoperitoneal (VP) Shunt market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Ventriculoperitoneal (VP) Shunt market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Fixed Pressure Valves
Variable Pressure Valves
Segment by Application
Hospitals
Clinics and Ambulatory Care centers
Laboratories
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Sophysa
Aesculap
B. Braun Melsungen
Integra lifesciences
Medtronic